エピソード

  • Novartis’s Christian Diehl on scaling AI beyond the demo

    Novartis’s Christian Diehl on scaling AI beyond the demo
    2026/09/17

    Novartis’s chief data and digital officer for biomedical research explains how data platform investments are paying off in AI safety prediction, generative chemistry, and faster translation

    See www.mckinsey.com/privacy-policy for privacy information
    続きを読む 一部表示
    42 分
  • AstraZeneca's Bob Li on the MARS mission to eliminate cancer

    AstraZeneca's Bob Li on the MARS mission to eliminate cancer
    2026/08/31

    Bob Li, AstraZeneca's Senior Vice President, Global Head of Medical Affairs, Oncology, on why only seven percent of cancer patients get access to clinical trials, and what decentralized trials, AI, and international collaboration could do to change that within a decade.

    See www.mckinsey.com/privacy-policy for privacy information
    続きを読む 一部表示
    38 分
  • McKinsey’s Fangning Zhang on China’s growing role in life sciences R&D

    McKinsey’s Fangning Zhang on China’s growing role in life sciences R&D
    2026/08/24

    McKinsey partner Fangning Zhang discusses what’s driving China’s acceleration in drug discovery, why intense competition is fueling speed and cost efficiency, and what global R&D leaders need to do to build a genuine China strategy.

    See www.mckinsey.com/privacy-policy for privacy information
    続きを読む 一部表示
    28 分
  • Bayer’s Sai Jasti on driving productivity in R&D with data science and AI

    Bayer’s Sai Jasti on driving productivity in R&D with data science and AI
    2026/07/28

    Bayer’s Senior Vice President and Head of Data Science and AI, Sai Jasti, on how the company is transforming its workflows and embedding AI in research and development to meet ambitious productivity goals.

    See www.mckinsey.com/privacy-policy for privacy information
    続きを読む 一部表示
    31 分
  • Bristol Myers Squibb CDTO Greg Meyers on biopharma’s AI-enabled future

    Bristol Myers Squibb CDTO Greg Meyers on biopharma’s AI-enabled future
    2025/11/05

    Greg Meyers, Executive Vice President and Chief Digital & Technology Officer at Bristol Myers Squibb (BMS) discusses how technology can be leveraged to drive outcomes.

    See www.mckinsey.com/privacy-policy for privacy information
    続きを読む 一部表示
    30 分
  • Lykke Hinsch Gylvin on the cutting edge of clinical trial design

    Lykke Hinsch Gylvin on the cutting edge of clinical trial design
    2025/10/06

    Lykke Hinsch Gylvin shares how Boehringer Ingelheim’s innovative clinical trial designs bring therapies to patients faster.

    See www.mckinsey.com/privacy-policy for privacy information
    続きを読む 一部表示
    24 分
  • Genentech’s John Marioni on enhancing drug discovery with data and AI

    Genentech’s John Marioni on enhancing drug discovery with data and AI
    2025/06/06

    John Marioni discusses how he and his teams across industries and academia use evolving technologies to bring sophisticated drug therapies to patients.

    See www.mckinsey.com/privacy-policy for privacy information
    続きを読む 一部表示
    32 分
  • J&J’s Ashita Batavia on advancing oncology clinical-trials with data

    J&J’s Ashita Batavia on advancing oncology clinical-trials with data
    2025/03/27

    In this episode of Eureka!, a McKinsey podcast on innovation in life sciences R&D, hosts Navraj Nagra, Alex Devereson, and Meredith Langstaff speak to Ashita Batavia, head of hematology and oncology data sciences, R&D, at Johnson & Johnson Innovative Medicine (J&J). They discuss how real-world data can better inform clinical trials, the shifts in mindsets and capabilities needed to support AI in biopharma, and how to navigate the complexity of clinical trials with more-pragmatic trial designs.

    See www.mckinsey.com/privacy-policy for privacy information
    続きを読む 一部表示
    32 分